Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...

PAHO is tracking a rise in dengue serogroup 3 activity, which could raise the risk of severe illness as countries approach the peak of the season.

Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...

President Donald Trump's nominees to run the National Institutes of Health and the Food and Drug Administration are part of a group of scientists censored during the COVID-19 pandemic who are ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

The founding director of the FDA’s Office of Biotechnology writes that new evidence suggests COVID may be a novel, additional ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

A second subtype of H5 bird flu, known as D1.1, was detected in dairy cattle and infected one worker in the US state of ...

StockNews.com initiated coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the biotechnology ...